Skip to content

Acceptability testing of a Decision Support Tool for patients and relatives that are deciding about being screened for Thoracic Aortic Disease

Mixed methods co-design and evaluation of a decision support tool to enable shared decision making for people who are considering cascade screening for thoracic aortic disease: the DECIDE-TAD Programme. Acceptability Testing Work Package 1.4

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN15536599
Enrollment
71
Registered
2025-09-23
Start date
2025-09-12
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic aortic disease Circulatory System

Interventions

For this component of the NIHR programme – Acceptability Testing – we will conduct qualitative interviews with TAD patients and their first and second-degree relatives as well as Health Care Professio

Sponsors

University of Leicester
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 200 Years

Inclusion criteria

Inclusion criteria: 1. People with a diagnosis of NS-TAD where this is defined as: 1.1. People with Acute Type A dissection, treated or untreated 1.2. People who have undergone non-emergency treatment (surgical or endovascular) for NS-TAD. This means anyone with NS-TAD who has had treatment at a UK cardiac surgery centre Or first- or second-degree relative of a patient with TAD Or healthcare professional involved in shared decision making consultations regarding screening for TAD 2. Aged 16 years and above 3. Diagnosed in the last 24 months from start date of this study when recruiting from Trusts (relevant for the patient with TAD) 4. Ability to understand the languages in which the information is available (Acceptability questionnaire study only) 5. Willingness to provide informed consent

Exclusion criteria

Exclusion criteria: 1. Previous diagnosis of syndromic TAD (relevant for the patient with TAD) 2. Inability to understand English written and spoken language (Acceptability questionnaire study only)

Design outcomes

Primary

MeasureTime frame
The acceptability of DST, assessed through an interview or a questionnaire with patients with TAD and their first- and second-degree relatives at a single timepoint for each participant

Secondary

MeasureTime frame
The feasibility of implementing a DST in clinical services and what training would be required to support delivery, assessed through interviews with healthcare professionals at a single timepoint for each participant

Countries

England, United Kingdom

Contacts

Public ContactJane Hughes
jane.hughes2@sheffield.ac.uk+44 (0)7756959752

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 3, 2026